James Rani, Chetry Rosy, Subramanian Vignesh, Ashtekar Abhishek, Srikruthi Nandagiri, Ramachandran Sankar, Koka Prasad S, Deb Kaushik
Merisis Therapeutics, DiponEd BioIntelligence, Bangalore, Karnataka, India.
J Stem Cells. 2016;11(4):191-199.
Platelet-rich plasma (PRP) has shown remarkable beneficial effects without any major adverse reactions in the treatment of androgenic alopecia .The growth factors in activated autologous PRP induces the proliferation of dermal papilla cells.
To investigate the clinical efficacy of Platelet Rich Plasma prepared using Merisis One Step Gel Separation Technology in treatment of androgenic alopecia.
Five patients were given autologous PRP injections on the affected area of alopecia over a period of three months at interval of two - three weeks and results were assessed.
Three months after the treatment, the patients presented clinical improvement in the hair counts, hair thickness, hair root strength and overall alopecia.
PRP appears to be a cheap, effective and promising therapy for androgenic alopecia with no major adverse effects.
富血小板血浆(PRP)在雄激素性脱发的治疗中显示出显著的有益效果,且无任何重大不良反应。活化的自体PRP中的生长因子可诱导毛乳头细胞增殖。
研究采用Merisis一步凝胶分离技术制备的富血小板血浆治疗雄激素性脱发的临床疗效。
五名患者在三个月内每隔两到三周在脱发患处进行自体PRP注射,并对结果进行评估。
治疗三个月后,患者在头发数量、头发厚度、发根强度和整体脱发情况方面有临床改善。
PRP似乎是一种治疗雄激素性脱发的廉价、有效且有前景的疗法,且无重大不良反应。